IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial 

February 23, 2026

Read More »

IGC Pharma, Inc. 424B5 01-06-26

January 6, 2026

Read More »

IGC Pharma, Inc 8-K 01-06-26

January 6, 2026

Read More »

IGC Pharma, Inc 8-K 01-02-26

January 2, 2026

Read More »

IGC Pharma, Inc 8-K 12-15-25

December 15, 2025

Read More »

IGC Pharma, Inc. Form S-3A 12-3-25

December 3, 2025

Read More »

IGC Pharma, Inc. Form S-3 11-14-25

November 14, 2025

Read More »

IGC Pharma, Inc. Form 8-K 11-14-25

November 14, 2025

Read More »

IGC Pharma, Inc. Form S-8 10-31-25

October 31, 2025

Read More »

IGC Pharma, Inc 8-K 10-10-25

October 10, 2025

Read More »

IGC Pharma, Inc 8-K 10-01-25

October 1, 2025

Read More »

IGC Pharma, Inc. Form 10-Q 09-30-25

September 30, 2025

Read More »

IGC Pharma, Inc. 424B5 09-19-25

September 19, 2025

Read More »

IGC Pharma 10-K 03-31-25

August 19, 2025

Read More »

DEFA 14A 08-18-25

August 19, 2025

Read More »

DEF 14A 08-18-25

August 19, 2025

Read More »